Laverock Therapeutics
Laverock Therapeutics develops programmable advanced therapies using a gene silencing platform that responds to specific cell identities and environmental conditions. The technology enables precise, tunable control of gene expression levels for applications in cell therapy, gene therapy, and oncology. The company offers these modular platforms for internal pipeline development and through collaborative partnerships for therapeutic and non-therapeutic applications.
Visit websiteStevenage, UK
Healthtech
Biotechnology
Gene Therapy
Oncology
Funding summary
- Total raised
- €25.7M
- Funding rounds
- 3
Investors in Laverock Therapeutics
Investors on record for Laverock Therapeutics. Click any investor to view their CAPLINK profile and funding criteria.
Fundraising for a startup like Laverock Therapeutics?
Explore CAPLINK's investor database of thousands of active VCs and angels.
Browse investors